Encodia Revenue and Competitors

Claim your profile

Location

$75M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Encodia's estimated annual revenue is currently $16.3M per year.(i)
  • Encodia's estimated revenue per employee is $155,000
  • Encodia's total funding is $75M.

Employee Data

  • Encodia has 105 Employees.(i)
  • Encodia grew their employee count by 50% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.7M619%$53MN/A
#2
$34.3M17717%$110MN/A
#3
$0.4M2735%$236.7MN/A
#4
$34.5M178-5%$160MN/A
#5
$3.7M2420%N/AN/A
#6
$147.3M3212%$192.5MN/A
#7
$17.5M113-3%$24.1MN/A
#8
$2.7M4379%N/AN/A
#9
$34.1M220100%N/AN/A
#10
$47.1M304-3%N/AN/A

Encodia is an emerging, early stage biotech company developing the next generation of protein analysis tools. We are seeking to recruit an experienced Staff Engineer overseeing Instrument Engineering Design and System Architecture. The successful candidate will have experience in designing a fluidics-based instrument to integrate and automate multi-step biochemical/chemical process steps. This individual will work closely with the chemistry and assay development teams to define possible system architectures and perform early prototyping/breadboarding experiments. For this and other open jobs see: encodia.workable.com.

keywords:N/A

$75M

Total Funding

105

Number of Employees

$16.3M

Revenue (est)

50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Encodia News

2019-07-15 - Libro SEO Audit avanzato

Davide Prevosto, co-fondatore di Encodia, Web Agency specializzata nella realizzazione di siti e applicazioni per il web, è full-stack developer da oltre 15 anni ...

2018-10-24 - Single-Molecule Proteomics Approach Could Enable ...

Another apparent entrant in the space is Encodia, a San Diego-based start-up that according to its website is "developing new technologies to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.1M10521%N/A
#2
$37.1M1056%N/A
#3
$9.9M1059%N/A
#4
$23.3M106-1%N/A
#5
$3.5M10663%N/A